Cell Transplantation for Parkinson's Disease: Present Status

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2004 Jun 23

PMID 15206816

Citations 7

Authors

Rene Drucker-Colin

Leticia Verdugo-Diaz

Affiliations

Soon will be listed here.

Abstract

1. Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of neurons in the substantia nigra pars compacta and a striatal deficiency of dopamine. PD typically affects people in late middle age and progresses slowly. In the early stages of the disease, treatment targeting the dopaminergic network is effective. However, with disease progression, transplantation is an option for repairing and replacing missing dopaminergic neurons. 2. In this review, we evaluate the tissue grafts and cellular therapies that have and are being considered. Clinical trials were originally derived from transplants of adrenal medullary chromaffin cells and embryonic nigral dopaminergic neurons in patients with PD. 3. Recently, novel molecular and cellular treatments are being utilized in animals and these include embryonic stem cells, fetal cells from pigs, or transfected cells. In spite of new molecular techniques and some 20 years of experience, the transplantation therapy for PD has today the same problems and results as the first reports which used neural fetal tissue or adrenal grafts.

Citing Articles

Mesenchymal stromal cell biotherapy for Parkinson's disease premotor symptoms.

Sun J, Zhang W, Wei Z, Song X, Jian L, Jiang F Chin Neurosurg J. 2023; 9(1):28.

PMID: 37833807 PMC: 10571301. DOI: 10.1186/s41016-023-00338-z.

Generation of Adrenal Chromaffin-like Cells from Human Pluripotent Stem Cells.

Abu-Bonsrah K, Zhang D, Bjorksten A, Dottori M, Newgreen D Stem Cell Reports. 2017; 10(1):134-150.

PMID: 29233551 PMC: 5768882. DOI: 10.1016/j.stemcr.2017.11.003.

A defined, controlled culture system for primary bovine chromaffin progenitors reveals novel biomarkers and modulators.

Masjkur J, Levenfus I, Lange S, Arps-Forker C, Poser S, Qin N Stem Cells Transl Med. 2014; 3(7):801-8.

PMID: 24855275 PMC: 4073824. DOI: 10.5966/sctm.2013-0211.

Preconditioning as a potential strategy for the prevention of Parkinson's disease.

Golpich M, Rahmani B, Mohamed Ibrahim N, Dargahi L, Mohamed Z, Raymond A Mol Neurobiol. 2014; 51(1):313-30.

PMID: 24696268 DOI: 10.1007/s12035-014-8689-6.

Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla.

Santana M, Chung K, Vukicevic V, Rosmaninho-Salgado J, Kanczkowski W, Cortez V Stem Cells Transl Med. 2012; 1(11):783-91.

PMID: 23197690 PMC: 3659667. DOI: 10.5966/sctm.2012-0022.

References

Date I, Ohmoto T . Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp Neurol. 1996; 137(2):333-44. DOI: 10.1006/exnr.1996.0034. View

Fine A, Hunt S, Oertel W, Nomoto M, Chong P, Bond A . Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Prog Brain Res. 1988; 78:479-89. DOI: 10.1016/s0079-6123(08)60321-0. View

Drucker-Colin R, Verdugo-Diaz L, Mendez M, Carrillo-Ruiz J, Morgado-Valle C, Hernandez-Cruz A . Comparison between low frequency magnetic field stimulation and nerve growth factor treatment of cultured chromaffin cells, on neurite growth, noradrenaline release, excitable properties, and grafting in nigrostriatal lesioned rats. Mol Cell Neurosci. 1994; 5(6):485-98. DOI: 10.1006/mcne.1994.1060. View

Kolarik J, Nadvornik P, Dvorak M, Andrs M . Crossed transvertebral puncture to block spinal ganglion in treatment of pain. Zentralbl Neurochir. 1988; 49(3):185-8. View

Peterson D, PRICE M, SMALL C . Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology. 1989; 39(2 Pt 1):235-8. DOI: 10.1212/wnl.39.2.235. View

Penn R, Goetz C, Tanner C, Klawans H, Shannon K, Comella C . The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. Neurosurgery. 1988; 22(6 Pt 1):999-1004. DOI: 10.1227/00006123-198806010-00004. View

Holden C . Neuroscience. Versatile cells against intractable diseases. Science. 2002; 297(5581):500-2. DOI: 10.1126/science.297.5581.500. View

Kelly P, Ahlskog J, Van Heerden J, Carmichael S, Stoddard S, Bell G . Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clin Proc. 1989; 64(3):282-90. DOI: 10.1016/s0025-6196(12)65248-3. View

Perlow M, Kokoris G, Gibson M, Silverman A, Kreiger D, Zimmerman E . Accessory olfactory bulb transplants correct hypogonadism in mutant mice. Brain Res. 1987; 415(1):158-62. DOI: 10.1016/0006-8993(87)90280-0. View

10.

Albin R, Young A, Penney J . The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989; 12(10):366-75. DOI: 10.1016/0166-2236(89)90074-x. View

11.

Lopez Lozano J, Bravo G, Abascal J, Brera B, Santos H . Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. CHP Neural Transplantation Group. Lancet. 1992; 339(8790):430. DOI: 10.1016/0140-6736(92)90115-j. View

12.

Allen G, Burns R, Tulipan N, Parker R . Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients. Arch Neurol. 1989; 46(5):487-91. DOI: 10.1001/archneur.1989.00520410021016. View

13.

Clark W . NEURONAL DIFFERENTIATION IN IMPLANTED FŒTAL CORTICAL TISSUE. J Neurol Psychiatry. 2011; 3(3):263-72. PMC: 1088186. DOI: 10.1136/jnnp.3.3.263. View

14.

Check E . Parkinson's patients show positive response to implants. Nature. 2002; 416(6882):666. DOI: 10.1038/416666a. View

15.

Madrazo I, Franco-Bourland R, Ostrosky-Solis F, Aguilera M, Cuevas C, Alvarez F . Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience. Prog Brain Res. 1990; 82:593-602. DOI: 10.1016/s0079-6123(08)62649-7. View

16.

Sladek Jr J, Redmond Jr D, Collier T, Blount J, Elsworth J, Taylor J . Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res. 1988; 78:497-506. DOI: 10.1016/s0079-6123(08)60323-4. View

17.

Lindvall O, Backlund E, Farde L, Sedvall G, Freedman R, Hoffer B . Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol. 1987; 22(4):457-68. DOI: 10.1002/ana.410220403. View

18.

Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S . Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med. 1997; 3(3):350-3. DOI: 10.1038/nm0397-350. View

19.

Halasz B, PUPP L, UHLARIK S, TIMA L . Further studies on the hormone secretion of the anterior pituitary transplanted into the hypophysiotrophic area of the rat hypothalamus. Endocrinology. 1965; 77(2):343-55. DOI: 10.1210/endo-77-2-343. View

20.

Drucker-Colin R, Verdugo-Diaz L, Morgado-Valle C, Ondarza R, Boll C, Miranda G . Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient. A preliminary report. Arch Med Res. 1999; 30(1):33-9. DOI: 10.1016/s0188-0128(98)00007-4. View